293 related articles for article (PubMed ID: 35832170)
1. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma.
Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG
Front Neurol; 2022; 13():861438. PubMed ID: 35832170
[TBL] [Abstract][Full Text] [Related]
2. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
Zhao J; Liu Z; Zheng X; Gao H; Li L
Front Genet; 2021; 12():753680. PubMed ID: 34819946
[No Abstract] [Full Text] [Related]
5. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
[TBL] [Abstract][Full Text] [Related]
6. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
7. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
Front Oncol; 2020; 10():578809. PubMed ID: 33330055
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
[No Abstract] [Full Text] [Related]
12. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
13. Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma.
Wang J; Ren J; Liu J; Zhang L; Yuan Q; Dong B
Bosn J Basic Med Sci; 2022 Sep; 22(5):728-750. PubMed ID: 35276059
[TBL] [Abstract][Full Text] [Related]
14. Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients.
Xu D; Li P; Zhang C; Shen Y; Cai J; Wei Q; Cao M; Xu Z; Wu D; Wang H; Bi X; Wang B; Li K
Stem Cells Int; 2024; 2024():2062283. PubMed ID: 38229597
[TBL] [Abstract][Full Text] [Related]
15. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
Peng J; Hao Y; Rao B; Zhang Z
Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
[TBL] [Abstract][Full Text] [Related]
16. A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma.
Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X
Front Cell Dev Biol; 2021; 9():675555. PubMed ID: 34095147
[TBL] [Abstract][Full Text] [Related]
17. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
[No Abstract] [Full Text] [Related]
18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Chen Z; Wu T; Yan Z; Zhang M
Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
[TBL] [Abstract][Full Text] [Related]
19. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma.
Wen J; Zhao W; Shu X
Front Oncol; 2022; 12():1087762. PubMed ID: 36776374
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
